>>> US Research Calls I

Research Calls I
  • Upgrades
    • LM Funding (LMFA) upgraded to Buy from Neutral at H.C. Wainwright, tgt $5
    • MiNK Therapeutics (INKT) upgraded to Buy from Neutral at H.C. Wainwright, tgt $35
    • PAR Technology (PAR) upgraded to Buy from Neutral at BTIG Research, tgt $65
    • Precigen (PGEN) upgraded to Neutral from Underweight at JPMorgan
    • Salesforce (CRM) upgraded to Neutral from Underperform at DA Davidson, tgt $225
    • Wingstop (WING) upgraded to Strong Buy from Outperform at Raymond James, tgt $420
    • Williams (WMB) upgraded to Outperformer from Neutral at CIBC, tgt $64
  • Downgrades
    • Applied Industrial (AIT) downgraded to Market Perform at Raymond James
    • Applied Materials (AMAT) downgraded to Neutral from Buy at BofA Securities, tgt $180
    • Applied Materials (AMAT) downgraded to Hold from Buy at Summit Insights
    • BJ's Wholesale (BJ) downgraded to Hold from Buy at Gordon Haskett, tgt $105
    • Cisco (CSCO) downgraded to Hold from Buy at HSBC, tgt $69
    • Consolidated Edison (ED) downgraded to Underperform from Buy at BofA Securities, tgt $101
    • Gambling.com (GAMB) downgraded to Hold from Buy at Truist, tgt $11
    • Globant (GLOB) downgraded to Neutral from Overweight at JPMorgan, tgt $78
    • Sabre (SABR) downgraded to Neutral from Buy at Rothschild & Co Redburn, tgt $2.40
    • Schrodinger (SDGR) downgraded to Neutral from Buy at Citigroup, tgt $20
    • Spire (SR) downgraded to Underperform from Neutral at BofA Securities, tgt $76
    • Target (TGT) downgraded to Underperform from Neutral at BofA Securities, tgt $93
  • Others
    • Avalo Therapeutics (AVTX) initiated with an Overweight at Cantor Fitzgerald
    • Climb Bio (CLYM) initiated with an Outperform at Robert W. Baird, tgt $9
    • Evolv (EVLV) reinstated with a Buy at TD Cowen, tgt $10
    • Exodus Movement (EXOD) initiated with an Overweight at Cantor Fitzgerald, tgt $45
    • ICU Medical (ICUI) initiated with an Overweight at Piper Sandler, tgt $145
    • MBX Biosciences (MBX) assumed with a Buy at Jefferies, tgt $36
    • MYR Group (MYRG) initiated with a Hold at Jefferies, tgt $202
    • Parker-Hannifin (PH) initiated with a Positive at Susquehanna, tgt $860
    • Revolution Medicines (RVMD) initiated with an Overweight at Wells Fargo, tgt $67
    • Skye Bioscience (SKYE) initiated with an Outperform at Evercore ISI, tgt $10